LncRNA MIR100HG Promotes Cancer Cell Proliferation, Migration and Invasion in Laryngeal Squamous Cell Carcinoma Through the Downregulation of MiR-204-5p

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2019 May 23

PMID 31114240

Citations 24

Authors

Yongyang Huang

Chao Zhang

Yanhui Zhou

Affiliations

Soon will be listed here.

Abstract

LncRNA MIR100HG promotes several types of malignancies, while its involvement in other human diseases is unknown. Our study included 70 patients with LSCC who were diagnosed and treated in the First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology from January 2016 to July 2018. qRT-PCR, cell transfection, in vitro cell proliferation assay, cell migration and invasion assay were applied for the research. In the present study we found that MIR100HG was upregulated, while miR-204-5p was downregulated in tumor tissues than in adjacent healthy tissues of laryngeal squamous cell carcinoma (LSCC) patients. Expression of MIR100HG was significantly affected by AJCC stage. A significant and inverse correlation between MIR100HG and miR-204-5p was found in tumor tissues but not in adjacent healthy tissues of LSCC patients. Overexpression of MIR100HG resulted in the downregulation of miR-204-5p in LSCC cells, while miR-204-5p overexpression failed to significantly affect MIR100HG expression. Overexpression of MIR100HG led to promoted, while miR-204-5p, overexpression led to inhibited proliferation, migration and invasion of LSCC cells. In addition, miR-204-5p overexpression attenuated the enhancing effects of MIR100HG overexpression on cancer cell proliferation, migration and invasion. Therefore, lncRNA MIR100HG promoted cancer cell proliferation, migration and invasion in LSCC possibly through the downregulation of miR-204-5p.

Citing Articles

Exosomal lncRNA LINC02191 Promotes Laryngeal Squamous cell Carcinoma Progression by Targeting miR-204-5p/RAB22A Axis and Regulating PI3K/Akt/mTOR Pathway.

Kang Z, Zhang C, Huangfu H Biochem Genet. 2023; 62(3):2117-2133.

PMID: 37863866 DOI: 10.1007/s10528-023-10541-3.

Exosomal lncRNA Mir100hg derived from cancer stem cells enhance glycolysis and promote metastasis of lung adenocarcinoma through mircroRNA-15a-5p/31-5p.

Shi L, Li B, Zhang Y, Chen Y, Tan J, Chen Y Cell Commun Signal. 2023; 21(1):248.

PMID: 37735657 PMC: 10512609. DOI: 10.1186/s12964-023-01281-3.

A concise review on the role of MIR100HG in human disorders.

Ghafouri-Fard S, Harsij A, Farahzadi H, Hussen B, Taheri M, Mokhtari M J Cell Mol Med. 2023; 27(16):2278-2289.

PMID: 37487022 PMC: 10424294. DOI: 10.1111/jcmm.17875.

Long non‑coding RNA PTCSC3 suppresses triple‑negative breast cancer by downregulating long non‑coding RNA MIR100HG.

Zhang G, Gao L, Zhang J, Wang R, Wei X Oncol Lett. 2023; 26(2):331.

PMID: 37415630 PMC: 10320428. DOI: 10.3892/ol.2023.13917.

Network analysis of long non-coding RNA expression profiles in common warts.

Tarkhan A, Al-Eitan L, Alkhatib R, Alghamdi M Heliyon. 2022; 8(11):e11790.

PMID: 36458289 PMC: 9706709. DOI: 10.1016/j.heliyon.2022.e11790.

References

Mork J, Lie A, Glattre E, Hallmans G, Jellum E, Koskela P . Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001; 344(15):1125-31. DOI: 10.1056/NEJM200104123441503. View

Taft R, Pang K, Mercer T, Dinger M, Mattick J . Non-coding RNAs: regulators of disease. J Pathol. 2009; 220(2):126-39. DOI: 10.1002/path.2638. View

Esteller M . Non-coding RNAs in human disease. Nat Rev Genet. 2011; 12(12):861-74. DOI: 10.1038/nrg3074. View

Jalali S, Bhartiya D, Lalwani M, Sivasubbu S, Scaria V . Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One. 2013; 8(2):e53823. PMC: 3566149. DOI: 10.1371/journal.pone.0053823. View

Yoon J, Abdelmohsen K, Gorospe M . Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 2014; 34:9-14. PMC: 4163095. DOI: 10.1016/j.semcdb.2014.05.015. View

Ye S, Yang L, Zhao X, Song W, Wang W, Zheng S . Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer. Cell Biochem Biophys. 2014; 70(3):1849-58. DOI: 10.1007/s12013-014-0142-y. View

Yin Y, Zhang B, Wang W, Fei B, Quan C, Zhang J . miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A. Clin Cancer Res. 2014; 20(23):6187-99. DOI: 10.1158/1078-0432.CCR-14-1030. View

Liu L, Wang J, Li X, Ma J, Shi C, Zhu H . MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma. Biochem Biophys Res Commun. 2015; 457(4):621-6. DOI: 10.1016/j.bbrc.2015.01.037. View

Bishop J, Lewis Jr J, Rocco J, Faquin W . HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice. Semin Diagn Pathol. 2015; 32(5):344-51. DOI: 10.1053/j.semdp.2015.02.013. View

10.

Gama R, Carvalho A, Longatto Filho A, Scorsato A, Mendoza Lopez R, Rautava J . Detection of human papillomavirus in laryngeal squamous cell carcinoma: Systematic review and meta-analysis. Laryngoscope. 2015; 126(4):885-93. DOI: 10.1002/lary.25738. View

11.

Marur S, Forastiere A . Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clin Proc. 2016; 91(3):386-96. DOI: 10.1016/j.mayocp.2015.12.017. View

12.

Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu Y . LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 2016; 6:23892. PMC: 4820696. DOI: 10.1038/srep23892. View

13.

Gao W, Wu Y, He X, Zhang C, Zhu M, Chen B . MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1. J Cancer. 2017; 8(12):2356-2368. PMC: 5560155. DOI: 10.7150/jca.19470. View

14.

Yu C, Li L, Xie F, Guo S, Liu F, Dong N . LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification. Cardiovasc Res. 2017; 114(1):168-179. DOI: 10.1093/cvr/cvx180. View

15.

Diaz-Martinez M, Benito-Jardon L, Alonso L, Koetz-Ploch L, Hernando E, Teixido J . miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma. Cancer Res. 2017; 78(4):1017-1030. PMC: 5815895. DOI: 10.1158/0008-5472.CAN-17-1318. View

16.

Wang S, Ke H, Zhang H, Ma Y, Ao L, Zou L . LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci. Cell Death Dis. 2018; 9(8):805. PMC: 6057987. DOI: 10.1038/s41419-018-0869-2. View